Opportunity Information: Apply for PA 07 435

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Bioengineering Approaches to Energy Balance and Obesity (SBIR R43/R44)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.393 Cancer Cause and Prevention Research 93.399 Cancer Control 93.837 Cardiovascular Diseases Research 93.866 Aging Research.
  • This funding opportunity was created on Jan 26, 2009 and posted on Aug 20, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses.
  • Foreign institutions are not eligible to apply.
Apply for PA 07 435

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Bioengineering Approaches to Energy Balance and Obesity (SBIR R43/R44) opportunity, Funding Opportunity Number PA 07 435, is a National Institutes of Health (NIH) small business grant program focused on creating and testing new bioengineering technologies that can help researchers and clinicians better understand and address problems tied to energy balance. In practical terms, it targets the measurement and modification of how the body regulates energy intake (what and how much people consume) and energy expenditure (how the body uses energy through metabolism and activity), with the longer-term aim of supporting progress on weight control and obesity. The emphasis is on tools and technologies that can move the field forward by making energy balance research more precise, scalable, and clinically relevant.

A key feature of this announcement is its strong push toward innovative instrumentation and engineering-driven solutions. NIH is looking for projects that develop and validate novel sensors, devices, imaging methods, and other technical approaches that can be used to study or monitor eating behavior, metabolic processes, physical activity, and related physiological signals. The announcement explicitly expects these technologies to be developed and evaluated through collaboration between engineers and physical scientists, together with researchers from disciplines such as obesity, nutrition, physiology, behavioral science, or other relevant areas. That multidisciplinary angle is central: the goal is not just to invent a gadget, but to create something technically sound and biologically meaningful that can answer real research questions in energy balance and ultimately be usable by the broader scientific community.

The program is structured under the SBIR mechanism, meaning it is intended for small businesses developing products or enabling technologies with a clear development pathway. It supports Phase I (R43) work, typically aimed at establishing feasibility and developing early proof-of-concept, and Phase II (R44) work, which generally focuses on full development, optimization, validation, and steps that position the technology for broader use or commercialization. The opportunity also allows Fast Track applications, which combine Phase I and Phase II into a single submission to speed the transition from feasibility to development if the project is well positioned to move quickly. The announcement also notes that it runs in parallel with a companion FOA of the same scientific scope, PA 07 436, which uses the STTR mechanisms (R41/R42). The practical difference is that STTR requires a formal partnership with a non-profit research institution, while SBIR has different collaboration requirements; applicants choose the track that best fits their team structure and R&D plan.

In terms of what NIH expects these projects to accomplish, the central deliverable is a useful technology or research tool that expands what scientists can measure, image, model, or intervene on in the context of energy balance. While the immediate objective is to equip researchers with better tools to study energy intake and expenditure, the announcement makes clear that the eventual downstream impact should be to support therapeutic advances and behavioral changes related to obesity and weight management. That means successful projects are likely to be those that can demonstrate a credible link between the technology being developed and how it will enable new insights, better monitoring, improved interventions, or more effective translation into clinical or real-world settings.

Administrative and eligibility details matter for this program. The funding instrument type is a grant, and it falls under discretionary funding. There is no cost sharing or matching requirement. Eligibility is limited to small businesses, and foreign institutions are not eligible to apply, which is consistent with SBIR program rules. The opportunity was originally posted on August 20, 2007, with multiple receipt dates (rather than a single deadline), and it was later archived on September 5, 2010. The size and duration of awards are not fixed in the announcement because projects can vary widely in scope and maturity; NIH indicates that budgets and timelines will depend on the mechanism used (Phase I, Phase II, or Fast Track), the scientific and technical merit of applications, and the proposed costs and duration.

The announcement is associated with several CFDA numbers reflecting the cross-cutting health relevance of energy balance research, including 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health), along with areas tied to cancer research and control (93.393 and 93.399), cardiovascular diseases (93.837), and aging research (93.866). That mix signals that NIH views obesity and energy balance technologies as broadly applicable across major disease areas where weight, metabolism, nutrition, and activity play meaningful roles. For applicants, this reinforces the value of framing the technology not only as an engineering advance, but also as a tool that could be widely useful for studying or improving health outcomes in multiple related domains.

For anyone needing the full official details, NIH provided an Additional Information link to the archived program announcement (http://grants.nih.gov/grants/guide/pa-files/PA-07-435.html) and directs technical access questions to the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV.

Frequently Asked Questions (FAQs)

What is the Bioengineering Approaches to Energy Balance and Obesity (SBIR R43/R44) opportunity?

It is an NIH Small Business Innovation Research (SBIR) grant opportunity that supports the creation and testing of new bioengineering technologies to improve how researchers and clinicians study and address energy balance and obesity.

What is the Funding Opportunity Number (FON) for this program?

The Funding Opportunity Number is PA 07 435.

Which agency runs this funding opportunity?

The program is run by the National Institutes of Health (NIH).

What does "energy balance" mean in the context of this announcement?

Energy balance refers to the relationship between energy intake (what and how much people consume) and energy expenditure (how the body uses energy through metabolism and activity). The focus is on measuring and modifying these processes to support progress in weight control and obesity research.

What kinds of projects is NIH looking for under this announcement?

NIH is looking for innovative, engineering-driven tools and technologies that can advance energy balance research by making measurement, monitoring, modeling, imaging, or intervention more precise, scalable, and clinically relevant.

What types of technologies are specifically emphasized?

The announcement emphasizes novel sensors, devices, imaging methods, and other technical approaches that can be used to study or monitor eating behavior, metabolic processes, physical activity, and related physiological signals.

Is the goal to build a consumer product, a research tool, or both?

The central deliverable is a useful technology or research tool that expands what scientists can measure, image, model, or intervene on in energy balance. The longer-term intent is that these tools support downstream therapeutic advances and behavioral changes related to obesity and weight management.

Does this program require collaboration across disciplines?

Yes. The announcement explicitly expects technologies to be developed and evaluated through collaboration between engineers and physical scientists and researchers in relevant fields such as obesity, nutrition, physiology, behavioral science, or related disciplines.

Why is multidisciplinary collaboration important for this FOA?

The program is not just looking for a new device or instrument; it is looking for something that is technically strong and biologically meaningful, capable of answering real energy balance research questions and being usable by the broader scientific community.

What funding mechanism is used for this opportunity?

This opportunity uses the SBIR mechanisms R43 (Phase I) and R44 (Phase II).

What is Phase I (R43) intended to support?

Phase I typically supports establishing feasibility and developing early proof-of-concept for the proposed technology.

What is Phase II (R44) intended to support?

Phase II generally supports full development, optimization, validation, and work that positions the technology for broader use or commercialization.

What is an SBIR Fast Track application under this announcement?

Fast Track combines Phase I and Phase II into a single submission to speed the transition from feasibility to development when a project is well positioned to move quickly.

Is there a companion opportunity related to this announcement?

Yes. A companion funding opportunity with the same scientific scope is PA 07 436, which uses the STTR mechanisms (R41/R42).

How does the companion STTR opportunity differ from SBIR, based on the provided information?

The practical difference noted is that STTR requires a formal partnership with a non-profit research institution, while SBIR has different collaboration requirements. Applicants choose the track that best matches their team structure and R&D plan.

Who is eligible to apply?

Eligibility is limited to small businesses.

Are foreign institutions eligible to apply?

No. Foreign institutions are not eligible to apply, consistent with SBIR program rules.

Is cost sharing or matching required?

No. The announcement indicates there is no cost sharing or matching requirement.

What type of funding instrument is this?

The funding instrument type is a grant.

Is this discretionary or mandatory funding?

It is discretionary funding.

When was this opportunity originally posted?

It was originally posted on August 20, 2007.

Does the announcement have a single deadline?

No. The announcement indicates multiple receipt dates rather than a single deadline.

What is the status of this opportunity now?

The announcement was archived on September 5, 2010.

Are award size and project duration fixed?

No. The announcement does not fix award size or duration, noting that projects vary widely. NIH indicates budgets and timelines depend on the mechanism used (Phase I, Phase II, or Fast Track), the scientific and technical merit of applications, and the proposed costs and duration.

What is NIH expecting applicants to deliver by the end of the project?

The core expectation is a useful technology or research tool that expands capabilities to measure, image, model, or intervene in energy balance. The announcement also highlights an eventual downstream impact: enabling progress toward therapeutic advances and behavioral changes related to obesity and weight management.

How should applicants think about the impact of their technology?

Successful projects are likely to show a credible link between the technology and how it will enable new insights, better monitoring, improved interventions, or stronger translation into clinical or real-world settings.

Which CFDA numbers are associated with this announcement?

The announcement lists several CFDA numbers, including 93.286, 93.393, 93.399, 93.837, and 93.866.

What does the mix of CFDA numbers imply about the scope of this program?

It signals that NIH views obesity and energy balance technologies as broadly applicable across multiple major health areas where weight, metabolism, nutrition, and physical activity matter, including technological innovation for human health, cancer-related areas, cardiovascular diseases, and aging research.

Where can someone find the official archived announcement text?

NIH provided an Additional Information link to the archived program announcement at: http://grants.nih.gov/grants/guide/pa-files/PA-07-435.html

Who should be contacted for technical access questions about the announcement?

Technical access questions are directed to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more business programs for Engineering Companies, Bioengineering Companies

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Bioengineering Approaches to Energy Balance and Obesity (STTR R41/R42)

Previous opportunity: Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health SBIR R43/R44

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 435

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 435) also looked into and applied for these:

Funding Opportunity
Bioengineering Approaches to Energy Balance and Obesity (STTR R41/R42) Apply for PA 07 436

Funding Number: PA 07 436
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Competing Renewal Awards of SBIR Phase II Grants for Brain and Behavior Tools (R44) Apply for PA 08 056

Funding Number: PA 08 056
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
New Technologies for Transient Molecular Complex Characterization (SBIR R43/R44) Apply for PA 08 110

Funding Number: PA 08 110
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
New Technologies for Transient Molecular Complex Characterization (STTR R41/R42) Apply for PA 08 111

Funding Number: PA 08 111
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Probes and Instrumentation for Monitoring and Manipulating Nervous System Plasticity (SBIR R43/R44) Apply for PA 08 146

Funding Number: PA 08 146
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pharmacogenomics Research Network (U01/U19) Apply for RFA GM 10 001

Funding Number: RFA GM 10 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Energy Efficiency and Renewable Energy System Technology Research and Development (STTR R41/R42) Apply for PA 09 101

Funding Number: PA 09 101
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44) Apply for PA 09 100

Funding Number: PA 09 100
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mechanisms of Alcohol and Nicotine Co Dependence (R21) Apply for PA 09 098

Funding Number: PA 09 098
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Mechanisms of Alcohol and Nicotine Co Dependence (R01) Apply for PA 09 099

Funding Number: PA 09 099
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR R43/R44) Apply for PA 09 113

Funding Number: PA 09 113
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR R41/R42) Apply for PA 09 114

Funding Number: PA 09 114
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) Apply for PA 09 106

Funding Number: PA 09 106
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R21) Apply for PA 09 107

Funding Number: PA 09 107
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Integrative Cancer Biology Program (ICBP) Centers for Cancer Systems Biology (CCSB) (U54) Apply for RFA CA 09 011

Funding Number: RFA CA 09 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,000,000
Clinical Research Curriculum Award (K30) Apply for RFA RR 09 006

Funding Number: RFA RR 09 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R01) Apply for PA 09 122

Funding Number: PA 09 122
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biobehavioral Methods to Improve Outcomes Research (R21) Apply for PA 09 126

Funding Number: PA 09 126
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Exploratory Grants for Behavioral Research in Cancer Control (R21) Apply for PA 09 130

Funding Number: PA 09 130
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Interventions to Improve Palliative Care at the End of Life (R01) Apply for RFA NR 09 004

Funding Number: RFA NR 09 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 435", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.